What is IPF Phase 2 Study FG-3019?

Category: Others


IPF Phase 2 FG-3019 is a randomized, placebo controlled trial to study the effectiveness and safety for using the investigational medication FG-3019 for the treatment of IPF. Other study ID numbers include NCT01890265 and FGCL-3019-067.

No patients have reported taking IPF Phase 2 Study FG-3019.
Last updated:
There are no evaluations for IPF Phase 2 Study FG-3019.